News

Our latest work examines the real-world psychosocial impact of Automated Insulin Delivery (AID) systems, analyzing user experiences, quality of life, and daily diabetes burden.

dQ&A's latest diabetes research includes two presentations from our team at ATTD 2026, one of the world's leading stages for diabetes advancements.

Our AI instantly delivers powerful, actionable diabetes insights from one of the world’s richest diabetes datasets.

dQ&A is announcing upcoming data releases for our flagship products: Prescriber Perspectives (Europe) and Patient Voice (Europe).

dQ&A launched the beta of our next-gen AI Insights Platform—a breakthrough natural language solution providing instant, data-driven answers for the diabetes market.

The European Association for the Study of Diabetes (EASD) recently concluded in Vienna, marking an exceptional year of innovation and collaboration in diabetes research. EASD convenes top minds from around the world to set the course for diabetes care. We were proud to showcase our latest findings from the dQ&A team, now available as a downloadable poster.

For over 12 years, dQ&A has gathered primary data from diabetes healthcare practitioners (HCPs)—notably endocrinologists and primary care physicians—expanding our ‘Prescriber Perspectives’ tracker to five countries with insights from key prescribers and influencers.

When it comes to patient-reported outcome measures, getting better or worse is really the bottom line for a disease that sadly tends to get worse over time.